Belimumab 24-month treatment outcomes in patients with systemic lupus erythematosus (SLE) with high disease activity: Results from the OBSErve real-world study

著录项

• 来源
  《Clinical and experimental rheumatology》 |2015年第90期|共1页
• 作者

  Collins C.; DallEra M.; Macahilig C.; Molta C.; Kan H.; Koscielny V.; Chang D. J.;

  展开▼
• 作者单位

  MedStar Washington Hosp Ctr Washington DC USA;

  UCSF San Francisco CA USA;

  Med Data Analyt Parsippany NJ USA;

  GlaxoSmithKline Philadelphia PA USA;

  GlaxoSmithKline Res Triangle Pk NC USA;

  GlaxoSmithKline Brentford Middx England;

  GlaxoSmithKline Philadelphia PA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 免疫性疾病;
• 关键词